(56) on laryngeal squamous cell carcinoma found that high expression of tumor HLA-DR is associated with improved response to anti-PD-1 therapy (56), but this research focused on HLA-DR expressed by tumor cells and not specifically on CTLs. The gene discussed is PDCD1; the disease is laryngeal squamous cell carcinoma.